UCB

Showing 15 posts of 80 posts found.

UCB image

UCB opens Belgian pilot plant

September 17, 2012
Manufacturing and Production Amgen, Belgium, R&D, UCB

UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …

UCB signs new epilepsy research pact with Imperial

May 21, 2012
Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …

UCB launches ‘Parkinson’s Well-Being Map’

April 13, 2012
Medical Communications Parkinson's disease, UCB

UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …

EMG appoints two new senior members

April 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB

A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).   EMG is the voice of …

UCB nominates new board members

March 26, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …

UCB signs £3.6m research deal with Oxford University

March 20, 2012
Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …

roch_d_ucb

UCB chief executive to chair IMI

March 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …

UCB image

UCB releases ‘Epilepsy In Our Time’ video diaries

February 17, 2012
Medical Communications UCB, epilepsy

UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …

Cimzia results excite UCB in psoriatic arthritis

February 16, 2012
Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis

UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …

Otsuka and UCB scale down collaboration

January 16, 2012
Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …

UCB appoints Peter Theil as head of non-clinical development

November 28, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB

Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …

UCB will double staff at Swiss bioproduction facility

November 15, 2011
Manufacturing and Production UCB, manufacturing

Belgian pharmaceutical company UCB showcased its new bioproduction facility in Bulle, Switzerland, yesterday, saying that the workforce there looks set …

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011
Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

UCB teams up with Harvard for CNS research

March 2, 2011
Research and Development CNS, Harvard, UCB, academia, academic research, immunology

UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies. …

UCB plans €250m plant to meet Cimzia demand

December 29, 2010
Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing

Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …

The Gateway to Local Adoption Series

Latest content